Cerebras vs. SpaceX: Which Is the Better AI IPO Stock to Buy and Hold for the Next 10 Years?

The article compares two recently IPOed AI-linked companies and argues SpaceX is the stronger 10-year buy, supported by $18.7B in 2025 revenue, $11.4B from Starlink, and 10.3 million subscribers. Cerebras posted 75.7% 2025 revenue growth to $510M and $24.6B in remaining performance obligations, but remains highly dependent on OpenAI and trades at 90.2x trailing sales. Overall, the piece is constructive on both businesses but highlights execution and valuation risk, especially for Cerebras.

Analysis

The market is effectively separating infrastructure-with-demand from infrastructure-without-demand. The higher-quality second-order read is that both names are really financing vehicles for AI compute scarcity, but the winners will be the platforms that can turn contracted demand into delivery without destroying gross margin or balance sheet flexibility. That favors the company with an existing recurring cash engine and multiple monetization layers; the chip-centric story is more fragile because it is bottlenecked by manufacturing, customer concentration, and execution on deployment schedules.

The key near-term catalyst is not product launch, but conversion of backlog into recognized revenue and booked capacity into cash. If delivery slips even one quarter, the multiple compression could be violent because these are not “optional” AI bets — they are duration-sensitive claims on future capacity. In contrast, the more diversified infrastructure player can absorb a miss in one segment because its satellite and connectivity base subsidizes the capex cycle, reducing equity duration and lowering the probability of a permanent de-rating.

Consensus is underestimating how much of the upside is already embedded in the obvious AI partnerships. The more interesting contrarian angle is that the strongest beneficiary may be the cloud/distribution layer rather than the proprietary hardware layer: hyperscalers and channel partners can capture the recurring margin without owning the same execution risk. That creates a relative-value setup where enthusiasm for pure plays can overrun fundamentals while broader platform names rerate more gradually.

The main reversal risk is a capex shock or delivery miss rather than demand destruction. Over the next 3-6 months, watch for customer concentration headlines, deferred revenue conversion, and any sign that GPU/compute commitments are being repriced or terminated. Over 12-24 months, the question becomes whether AI compute remains scarce enough to support premium pricing, or whether supply expansion commoditizes the economics and compresses margins across the chain.

Key Decisions for Investors

• Favor long GOOGL over any pure-play AI compute beneficiary on a 6-12 month horizon: if compute contracts are real, hyperscalers capture the usage monetization with lower execution risk and better downside protection.
• If able to access private/secondary exposure, stay long the diversified infrastructure compounder versus the chip-centric IPO for a 2-3 year hold; the former has a better chance of compounding through multiple cycles with less dilution risk.
• Pair trade concept: long AMZN / short the more crowded AI-capex beneficiary basket for 3-6 months; the thesis is that distribution and cloud channels monetize AI demand with less customer concentration and more resilient margins.
• Avoid outright shorting the chip/IP0 story into strength unless there is a catalyst of missed delivery or contract slippage; instead, consider limited-risk put spreads 1-2 quarters out to express the view that the valuation is ahead of execution.
• If volatility stays elevated, use call spreads on GOOGL rather than chasing the pure-play names: asymmetric upside if AI demand broadens, with less risk of a multiple air pocket.